<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Rev Paul Pediatr</journal-id>
<journal-id journal-id-type="iso-abbrev">Rev Paul Pediatr</journal-id>
<journal-id journal-id-type="publisher-id">rpp</journal-id>
<journal-title-group>
<journal-title>Revista Paulista de Pediatria</journal-title>
</journal-title-group>
<issn pub-type="ppub">0103-0582</issn>
<issn pub-type="epub">1984-0462</issn>
<publisher>
<publisher-name>Sociedade de Pediatria de São Paulo</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32074228</article-id>
<article-id pub-id-type="pmc">7025444</article-id>
<article-id pub-id-type="doi">10.1590/1984-0462/2020/38/2018351</article-id>
<article-id pub-id-type="other">00425</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>IDENTIFICATION OF MUTATIONS IN THE <italic>PAH</italic> GENE IN PKU
PATIENTS IN THE STATE OF MATO GROSSO</article-title>
<trans-title-group xml:lang="pt">
<trans-title>IDENTIFICAÇÃO DE MUTAÇÕES NO GENE DA <italic>PAH</italic> EM
PACIENTES COM FENILCETONÚRIA DO ESTADO DE MATO GROSSO</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-3605-5818</contrib-id>
<name>
<surname>Costa</surname>
<given-names>Roseli Divino</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="corresp" rid="c1">*</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-4662-3567</contrib-id>
<name>
<surname>Galera</surname>
<given-names>Bianca Borsatto</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-4318-0112</contrib-id>
<name>
<surname>Rezende</surname>
<given-names>Bianca Costa</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-4951-7871</contrib-id>
<name>
<surname>Venâncio</surname>
<given-names>Amanda Cristina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-1624-7572</contrib-id>
<name>
<surname>Galera</surname>
<given-names>Marcial Francis</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<aff id="aff1">
<label>a</label>Universidade Federal de Mato Grosso, Cuiabá, MT, Brazil.</aff>
</contrib-group>
<author-notes>
<corresp id="c1"><label>*</label>Corresponding author. E-mail:
<email>roselibiologia@yahoo.com.br</email> (R.D. Costa).</corresp>
<fn fn-type="COI-statement" id="fn2">
<p>The authors declare no conflict of interests.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>38</volume>
<elocation-id>e2018351</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>4</month>
<year>2019</year>
</date>
<date date-type="online">
<day>07</day>
<month>2</month>
<year>2020</year>
</date>
</history>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the
Creative Commons Attribution License</license-p>
</license>
</permissions>
<abstract>
<title>ABSTRACT</title>
<sec>
<title>Objective:</title>
<p> To identify phenylalanine hydroxylase (<italic>PAH</italic>) mutations in
patients with phenylketonuria (PKU) from the Newborn Screening Service in
Mato Grosso, Midwest Brazil.</p>
</sec>
<sec>
<title>Methods:</title>
<p> This is a cross-sectional descriptive study. The sample consisted of 19 PKU
patients diagnosed by newborn screening. Molecular analysis: DNA extraction
using the “salting-out” method. Detection of IVS10nt-11G&gt;A, V388M, R261Q,
R261X, R252W, and R408W mutations by the restriction fragment length
polymorphism (RFLP) technique.</p>
</sec>
<sec>
<title>Results:</title>
<p> Two mutant alleles were identified in four patients (21.1%), one allele in
five patients (26.2%), and none in the remaining ten patients (52.6%). A
total of 13/38 alleles were detected, corresponding to 34.2% of the
<italic>PAH</italic> alleles present. The most prevalent variant was
V388M (13.2% of the alleles), followed by R261Q (10.1%) and IVS10nt-11G&gt;A
(7.9%). Three variants (R261X, R252W, and R408W) were not found. The most
frequent mutation types were: missense mutation in eight alleles (18.4%) and
splicing in four alleles (10.5%). The model proposed by Guldberg to
determine a genotype/phenotype correlation was applied to four classical PKU
patients with two identified mutations. In three of them, the predicted
moderate/moderate or moderate PKU phenotype did not coincide with the actual
diagnosis. The prediction coincided with the diagnosis of one classic PKU
patient. The estimated incidence of PKU for Mato Grosso, Brazil, was
1:33,342 live births from 2003 to 2015.</p>
</sec>
<sec>
<title>Conclusion:</title>
<p> The only mutations found in the analyzed samples were the IVS10nt-11G&gt;A,
V388M, and R261Q. The genotype/phenotype correlation only occurred in four
(5.3%) patients.</p>
</sec>
</abstract>
<trans-abstract xml:lang="pt">
<title>RESUMO</title>
<sec>
<title>Objetivo:</title>
<p> Identificar mutações da fenilalanina hidroxilase (PAH) em pacientes com PKU
(fenilcetonúria) do Serviço de Triagem Neonatal em Mato Grosso.</p>
</sec>
<sec>
<title>Métodos:</title>
<p> Estudo de corte transversal. Amostra composta de 19 pacientes com PKU
através do exame de triagem neonatal biológica. Análise molecular: a)
extração de DNA pela metodologia “<italic>salting out</italic>”. B) detecção
de mutações IVS10nt-11G&gt;A, V388M, R261Q, R261X, R252W e R408W pela
técnica de polimorfismo de comprimento de fragmento de restrição (RFLP).</p>
</sec>
<sec>
<title>Resultados:</title>
<p> Dois alelos foram identificados em quatro pacientes (21,1%), um alelo em
cinco pacientes (26,2%) e nenhum nos dez pacientes restantes (52,6%). Um
total de 13/38 alelos foram identificados, correspondendo a 34,2% dos alelos
PAH presentes. A variante mais prevalente foi a V388M (13,2% dos alelos),
seguida de R261Q (10,1%) e IVS10nt-11G&gt;A (7,9%). Três variantes (R261X,
R252W e R408W) não foram encontradas. Os tipos de mutações mais frequentes
foram: troca de sentido em oito alelos (18,4%) e emenda em quatro alelos
(10,5%). O modelo proposto por Guldberg para determinar uma correlação
genótipo/fenótipo foi aplicado para quatro pacientes clássicos de PKU, com
duas mutações identificadas. Em três, o fenótipo previsto de PKU
moderada/moderada ou moderada não coincidiu com o diagnóstico real. A
predição coincidiu com o diagnóstico de um paciente PKU clássico. A
incidência de PKU estimada para Mato Grosso, Brasil foi de 1:33.342 nascidos
vivos para o período de 2003 a 2015.</p>
</sec>
<sec>
<title>Conclusões:</title>
<p> Foram encontradas apenas as mutações IVS10nt-11G&gt;A, V388M, R261Q nas
amostras analisadas. A correlação genótipo/fenótipo ocorreu em quatro (5,3%)
pacientes.</p>
</sec>
</trans-abstract>
<kwd-group>
<title>Keywords:</title>
<kwd>Phenylketonuria</kwd>
<kwd>Mutations</kwd>
<kwd>Neonatal screening</kwd>
</kwd-group>
<kwd-group xml:lang="pt">
<title>Palavras-chave:</title>
<kwd>Fenilcetonúria</kwd>
<kwd>Mutações</kwd>
<kwd>Triagem neonatal</kwd>
</kwd-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="6"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="27"></ref-count>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Phenylketonuria (PKU, OMIM 261600)<xref ref-type="bibr" rid="B1">
<sup>1</sup>
</xref> is an inborn error of metabolism with an autosomal recessive inheritance,
predominantly caused by mutations in the phenylalanine hydroxylase
(<italic>PAH</italic>) gene. Mutations in the <italic>PAH</italic> gene impair
the EC 1.14.16.1 liver enzyme function that catalyzes the conversion of
L-phenylalanine (L-Phe) essential amino acids into L-tyrosine (L-Tyr), a precursor
of neurotransmitters (dopamine, noradrenaline, and adrenaline) and melanin.<xref ref-type="bibr" rid="B2">
<sup>2</sup>
</xref> The <italic>PAH</italic> gene is located on chromosome 12 (12q23.2),
spanning about 90 kbp in length. The gene contains 13 exons, encoding a 452 amino
acid polypeptide, and forming a 1359 base-pair reading transcript. To date, more
than 800 mutations have been described in the <italic>PAH</italic> gene.<xref ref-type="bibr" rid="B3">
<sup>3</sup>
</xref>
</p>
<p>PKU occurs in all ethnic groups and because of the large genetic variability,
prevalence may differ; the highest live birth rates were found in Ireland (1:4,500)
and Turkey (1:2,600), and the lowest rates in Finland, Japan, and Thailand
(1:200,000, 1:143,000, and 1:212,000 live births).<xref ref-type="bibr" rid="B4">
<sup>4</sup>
</xref> In Brazil, the incidence varies greatly: Sergipe (1:8,690), São Paulo
(1:19,409), Tocantins (1:28,309), Santa Catarina (1:28,862).<xref ref-type="bibr" rid="B5">
<sup>5</sup>
</xref> In 2012, the prevalence in 18 Brazilian States was 1:24,780 live
births.<xref ref-type="bibr" rid="B6">
<sup>6</sup>
</xref> According to Stranieri,<xref ref-type="bibr" rid="B7">
<sup>7</sup>
</xref> PKU prevalence in Mato Grosso was 1:33,068 live births in 2009.</p>
<p>Studies have shown substantial variability in <italic>PAH</italic> gene mutations,
which are not yet fully known in Brazil. The distribution <italic>PAH</italic> gene
mutations among the Brazilian population is highly inconsistent, according to the
few studies carried out on the subject. The IVS10nt-11G&gt;A mutation is more
frequent in studies conducted in Ribeirão Preto/São Paulo<xref ref-type="bibr" rid="B8">
<sup>8</sup>
</xref> (17.4%), while an investigation including samples from several States of
Northeast Brazil shows a 22.1% incidence rate, and a case study in Alagoas,
53%.<xref ref-type="bibr" rid="B8">
<sup>8</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B9">
<sup>9</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B10">
<sup>10</sup>
</xref> I65T mutation was highly prevalent in Rio Grande do Sul (19.5%), a rate
similar to that observed in Campinas (17.5%), São Paulo (Southeast Brazil).<xref ref-type="bibr" rid="B11">
<sup>11</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B12">
<sup>12</sup>
</xref> In Minas Gerais, also in the Southeast region of Brazil, the most frequent
mutation was V388M, found in 21.2% of the alleles.<xref ref-type="bibr" rid="B13">
<sup>13</sup>
</xref> V388M (12.7%), R261Q (11.8%), and IVS10-11G&gt;A (10.3%) were the most
frequently found mutations in the State of Rio de Janeiro.<xref ref-type="bibr" rid="B14">
<sup>14</sup>
</xref>
</p>
<p>Untreated PKU is associated with progressive intellectual disability, accompanied by
several additional symptoms, which may include eczematous eruption, autism,
seizures, and motor deficits. Developmental problems, aberrant behavior, and
psychiatric symptoms often become apparent as the child grows.<xref ref-type="bibr" rid="B15">
<sup>15</sup>
</xref> The standard treatment for PKU comprises two main joint strategies: a
phenylalanine-restricted diet and the use of amino acid-rich metabolic formula, free
of phenylalanine.<xref ref-type="bibr" rid="B16">
<sup>16</sup>
</xref> Thus, the identification of these mutations by molecular study is used as a
tool for an accurate PKU diagnosis, guiding the multidisciplinary team towards a
more efficient follow-up of the patient.</p>
<p>The objective of this study was to verify the molecular bases responsible for PKU, as
well as establish the genotype/phenotype correlation in individuals followed by the
Newborn Screening Reference Service at the Júlio Müller University Hospital/Federal
University of Mato Grosso (Hospital Universitário Júlio Müller/Universidade Federal
do Mato Grosso - HUJM/UFMT) in Mato Grosso (MT).</p>
</sec>
<sec sec-type="methods">
<title>METHOD</title>
<p>This is a cross-sectional study. The studied population consisted of patients
diagnosed with PKU during the newborn screening at the Newborn Screening Reference
Service of Mato Grosso (Serviço de Referência em Triagem Neonatal - SRTN/MT) in the
HUJM. The Human Research Ethics Committee of HUJM approved this research under the
number 1,486,868, dated April 4, 2016.</p>
<p>The National Newborn Screening Program (Programa Nacional de Triagem Neonatal -
PNTN), created by the Ministry of Health/Health Care Office - Regulation ­GM/­MS No.
822, 06/06/2001 -, aims to guarantee not only the screening in this population, that
is, tracking diseases included in the National Program, but also to allow children
diagnosed with any of these diseases to receive adequate treatment at an early
stage, providing an opportunity for proper intervention that can reduce morbidity
and mortality. The Ministry of Health (MoH) authorized the State of Mato Grosso in
2001, and UFMT was registered in 2002, through the HUJM, as an SRTN under Regulation
SAS/MS No. 684, dated October 4, 2002. In 2002, the service started working on Phase
I with congenital hypothyroidism (CH) and phenylketonuria (PKU). Since 2014, SRTN
has been working on phase IV of the program (Regulation No. 488, June 17, 2014).</p>
<p>The nominal variables analyzed were age, gender, consanguinity, and family
recurrence, along with the following epidemiological variables: PKU incidence in MT
and frequency of genotypes and phenotypes. A modified version of the salting-out
technique was used to extract the DNA.<xref ref-type="bibr" rid="B17">
<sup>17</sup>
</xref> The technique described by Saik et al.<xref ref-type="bibr" rid="B18">
<sup>18</sup>
</xref> was used to perform the polymerase chain reaction (PCR). We investigated the
most frequently found mutations in studies carried out in Brazil: IVS10nt-11G&gt;A,
V388M (exon 11-primers 5’TGAGAGAAGGGGCACAAATG3’D, 5’GCCAACCACCCACAGATGAG3’R), R261Q,
R261X, R252W (exon 7-primers 5’GGTGATGAGCTTTGAGTTTTCTTTC3’D,
5’AGCAAATGAACCCAAACCTC3’R), and R408W (exon 12 - 5’ATGCCACTGAGAACTCTCTT3’D,
5’GATTACTGAGAAACCGAGTGGCCT3’R)<xref ref-type="bibr" rid="B10">
<sup>10</sup>
</xref> through the restriction fragment length polymorphism (RFLP) technique.
Oligonucleotides from GBT Oligos - Custom Oligonucleotide Synthesis Certificate of
Analysis, supplied by Ludwig Biotec<sup>®</sup> (Alvorada-RS/Brazil), were used.</p>
<p>The PCR Master Mix (Ludwig Biotec<sup>®</sup>; Alvorada-RS/Brazil) was used according
to the package insert, and the DNA concentration was 100ng/µL. The PCR was performed
in the following conditions: initial denaturation at 94°C for five to six minutes,
followed by 35 denaturation cycles at 95°C for 30 seconds, annealing at 59°C for one
minute, extension at 72°C for 30 seconds, and a final extension at 72°C for five
minutes. In the case of exon 11, the annealing temperature was 61°C. For the
digestion phase, 5 U of endonucleases were used for all mutations, and the
incubation was done overnight at 37°C (<xref ref-type="table" rid="t1">Table
1</xref>). A 2% agarose gel electrophoresis was used and visualized directly on
the Molecular Imager ChemiDoc<sup>TM</sup> XRS transilluminator and the Image LabTM
Software, both from Bio-Rad<sup>®</sup> (Hercules, California, USA).</p>
<p>
<table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><title>PCR product size in base pairs for exons 7, 11, and 12 of the
phenylalanine hydroxylase gene, mutation, endonuclease used, and
fragments generated in base pairs.</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">Exon</th><th align="center" colspan="1" rowspan="1">PCR product</th><th align="center" colspan="1" rowspan="1">Mutations</th><th align="center" colspan="1" rowspan="1">Endonuclease</th><th align="center" colspan="1" rowspan="1">Fragment(s) after digestion - wild</th><th align="center" colspan="1" rowspan="1">Fragment(s) (bp) after digestion - mutated</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="3">7</td><td align="center" colspan="1" rowspan="3">263</td><td align="center" colspan="1" rowspan="1">R261Q <sup>a</sup>
</td><td align="center" colspan="1" rowspan="1">
<italic>Hinf</italic>I</td><td align="center" colspan="1" rowspan="1">116/147</td><td align="center" colspan="1" rowspan="1">263</td></tr><tr><td align="center" colspan="1" rowspan="1">R252W <sup>a</sup>
</td><td align="center" colspan="1" rowspan="1">
<italic>Aval</italic>
</td><td align="center" colspan="1" rowspan="1">86/177</td><td align="center" colspan="1" rowspan="1">263</td></tr><tr><td align="center" colspan="1" rowspan="1">R261X <sup>b</sup>
</td><td align="center" colspan="1" rowspan="1">
<italic>Ddel</italic>I</td><td align="center" colspan="1" rowspan="1">263</td><td align="center" colspan="1" rowspan="1">115/148</td></tr><tr><td align="left" colspan="1" rowspan="2">11</td><td align="center" colspan="1" rowspan="2">301</td><td align="center" colspan="1" rowspan="1">V388M <sup>a</sup>
</td><td align="center" colspan="1" rowspan="1">
<italic>BsaAI</italic>
</td><td align="center" colspan="1" rowspan="1">114/187</td><td align="center" colspan="1" rowspan="1">301</td></tr><tr><td align="center" colspan="1" rowspan="1">IVS10nt-11G&gt;A <sup>b</sup>
</td><td align="center" colspan="1" rowspan="1">
<italic>Ddel</italic>I</td><td align="center" colspan="1" rowspan="1">301</td><td align="center" colspan="1" rowspan="1">78/223</td></tr><tr><td align="left" colspan="1" rowspan="1">12</td><td align="center" colspan="1" rowspan="1">238</td><td align="center" colspan="1" rowspan="1">R408W <sup>b</sup>
</td><td align="center" colspan="1" rowspan="1">
<italic>Styl</italic>
</td><td align="center" colspan="1" rowspan="1">238</td><td align="center" colspan="1" rowspan="1">97/141</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>
<sup>a</sup>destroys restriction site; <sup>b</sup>creates
restriction site.</p></fn></table-wrap-foot></table-wrap>
</p>
<p>In order to establish a correlation between genotype and phenotype in PKU patients,
Guldberg et al.<xref ref-type="bibr" rid="B19">
<sup>19</sup>
</xref> created a model in which the sum of the arbitrary values (AV) for each
identified mutation would define the clinical phenotype, as shown in <xref ref-type="table" rid="t1">Table 1</xref>. Thus, clinical cases would be
classified as classical PKU, moderate PKU, mild PKU, and non-PKU
hyperphenylalaninemia (HPA), according to these values.</p>
<p>The frequencies were calculated as absolute numbers and percentages.</p>
</sec>
<sec sec-type="results">
<title>RESULTS</title>
<p>This study evaluated a total of 19 patients from 15 families. Their follow-up was
carried out at the SRTN/MT clinic of the HUJM/UFMT. Patients were distributed in the
following age groups: 0-10-year-olds (57.9%), 11-20, (36.8%) and &gt;20 (5.3%). Men
added up to 63.2% of the patients, among whom 15.8% showed consanguinity, and 21%
were siblings.</p>
<p>The SRTN/MT diagnosed 15 cases of PKU - one case in each of the years 2003, 2005,
2006, 2009, 2013, and 2014; two cases in each of the years 2008, 2010, 2011; and
three cases in 2012. Three patients were transferred to Mato Grosso from other
SRTNs, and one patient died.</p>
<p>Among the 19 patients participating in the study, four (21.1%) had their two mutant
alleles identified. Five patients (26.3%) had only one allele identified, and ten
patients (52.6%) remained without identified mutations. The study on the 6 described
mutations made it possible to detect 13/38 alleles, corresponding to 34.2% of the
PKU alleles of the sample. The most prevalent mutation was V388M (13.2% of the
alleles), followed by R261Q (10.1%), and IVS10nt-11-G&gt;A (7.9%). The R261X, R252W,
and R408W mutations were not identified. The most frequent mutations were missense
mutations, found in eight patients (18.4%), and splicing, found in four patients
(10.52%), as presented in <xref ref-type="table" rid="t2">Table 2</xref> and <xref ref-type="fig" rid="f1">Figure 1</xref>.</p>
<p>
<table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Genotypes identified in patients with phenylketonuria from the
Newborn Screening Reference Service of the State of Mato Grosso.</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">Patients</th><th align="center" colspan="1" rowspan="1">Genotypes</th><th align="center" colspan="1" rowspan="1">Exon</th><th align="center" colspan="1" rowspan="1">Mutation</th><th align="center" colspan="1" rowspan="1">Frequency</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">01</td><td align="center" colspan="1" rowspan="1">IVS10n-t11G&gt;A</td><td align="center" colspan="1" rowspan="1">11</td><td align="center" colspan="1" rowspan="1">Splice</td><td align="center" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">03</td><td align="center" colspan="1" rowspan="1">V388M</td><td align="center" colspan="1" rowspan="1">11</td><td align="center" colspan="1" rowspan="1">Missense</td><td align="center" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">06</td><td align="center" colspan="1" rowspan="1">R261Q</td><td align="center" colspan="1" rowspan="1">7</td><td align="center" colspan="1" rowspan="1">Missense</td><td align="center" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">07</td><td align="center" colspan="1" rowspan="1">R261Q</td><td align="center" colspan="1" rowspan="1">7</td><td align="center" colspan="1" rowspan="1">Missense</td><td align="center" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">08</td><td align="center" colspan="1" rowspan="1">R261Q</td><td align="center" colspan="1" rowspan="1">7</td><td align="center" colspan="1" rowspan="1">Missense</td><td align="center" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">08</td><td align="center" colspan="1" rowspan="1">V388M</td><td align="center" colspan="1" rowspan="1">11</td><td align="center" colspan="1" rowspan="1">Missense</td><td align="center" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">11</td><td align="center" colspan="1" rowspan="1">IVS10nt-11G&gt;A</td><td align="center" colspan="1" rowspan="1">11</td><td align="center" colspan="1" rowspan="1">Splice</td><td align="center" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">12</td><td align="center" colspan="1" rowspan="1">R261Q</td><td align="center" colspan="1" rowspan="1">7</td><td align="center" colspan="1" rowspan="1">Missense</td><td align="center" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">12</td><td align="center" colspan="1" rowspan="1">IVS10nt-11G&gt;A</td><td align="center" colspan="1" rowspan="1">11</td><td align="center" colspan="1" rowspan="1">Splice</td><td align="center" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">13</td><td align="center" colspan="1" rowspan="1">V388M</td><td align="center" colspan="1" rowspan="1">11</td><td align="center" colspan="1" rowspan="1">Missense</td><td align="center" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">13</td><td align="center" colspan="1" rowspan="1">IVS10nt-11G&gt;A</td><td align="center" colspan="1" rowspan="1">11</td><td align="center" colspan="1" rowspan="1">Splice</td><td align="center" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">14</td><td align="center" colspan="1" rowspan="1">V388M</td><td align="center" colspan="1" rowspan="1">11</td><td align="center" colspan="1" rowspan="1">Missense</td><td align="center" colspan="1" rowspan="1">1</td></tr></tbody></table></table-wrap>
</p>
<p>
<fig id="f1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Restriction fragment length polymorphism.</title></caption><graphic xlink:href="1984-0462-rpp-38-e2018351-gf1"></graphic></fig>
</p>
<p>The genotype/phenotype correlation was based on the multicenter study on
phenylalanine hydroxylase deficiency performed by Guldberg et al. in 1998.<xref ref-type="bibr" rid="B19">
<sup>19</sup>
</xref> This correlation was established from the predicted residual activities
induced by each mutation. AVs were determined for each mutation, based on their
characteristics: AV=1 - classical PKU mutation; AV=2 - moderate PKU mutation; AV=4 -
mild PKU mutation; and VA=8 - non-PKU. The identification of the two mutations
produced two AVs, and their sum would define the phenotype predicted by Guldberg et
al., creating four clinical variants: classical PKU, moderate PKU, mild PKU, and
non-PKU HPA, as shown in <xref ref-type="table" rid="t1">Table 1</xref>.<xref ref-type="bibr" rid="B12">
<sup>12</sup>
</xref> We used the first test performed in the newborn screening to apply the
classification proposed by Guldberg et al., as seen in <xref ref-type="table" rid="t3">Table 3</xref>.<xref ref-type="bibr" rid="B19">
<sup>19</sup>
</xref>
</p>
<p>
<table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Genotype/phenotype correlation.</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" colspan="1" rowspan="1">Genotype</th><th align="center" colspan="1" rowspan="1">Phenotype predicted </th><th align="center" colspan="1" rowspan="1">
<bold>Phenotype observed</bold>
</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">V388M</td><td align="center" colspan="1" rowspan="1">PKU moderate/mild</td><td align="center" colspan="1" rowspan="1">PKU classical</td></tr><tr><td align="left" colspan="1" rowspan="1">R261Q/V388M</td><td align="center" colspan="1" rowspan="1">PKU moderate/mild</td><td align="center" colspan="1" rowspan="1">PKU classical</td></tr><tr><td align="left" colspan="1" rowspan="1">R261Q/IVS10nt-11G&gt;A</td><td align="center" colspan="1" rowspan="1">PKU moderate/classical</td><td align="center" colspan="1" rowspan="1">PKU classical</td></tr><tr><td align="left" colspan="1" rowspan="1">V388M/IVS10nt-11G&gt;A</td><td align="center" colspan="1" rowspan="1">PKU moderate</td><td align="center" colspan="1" rowspan="1">PKU classical</td></tr></tbody></table></table-wrap>
</p>
<p>The incidence of PKU from 2003 to 2015 was 1:33,342 live births in the studied
population, according to samples collected at the SRTN. The average coverage of the
program in Mato Grosso from 2003 to 2015 was 75.2%, considering 664,943 births in
the same period. Also during the same period, five patients were transferred from
other Brazilian States.</p>
</sec>
<sec sec-type="discussion">
<title>DISCUSSION</title>
<p>The most frequently found mutation was V388M, located at exon 11, codon 1162
(c.1162G&gt;A) of the <italic>PAH</italic> gene, in the catalytic domain, consisting
of the substitution of the Valine (Val) amino acid for Methionine (Met).<xref ref-type="bibr" rid="B20">
<sup>20</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B21">
<sup>21</sup>
</xref> The V388M mutation was first described in a Japanese patient, is common in
the Iberian Peninsula, and has a relatively high frequency in São Paulo and
Chile.<xref ref-type="bibr" rid="B20">
<sup>20</sup>
</xref> It is associated with a severe phenotype and may result from the oxidation
of methionine to methionine sulfoxide. Such modification may disrupt the surface of
the protein at the interface between subunits and result in the destabilization of
the <italic>PAH</italic> tetramer set.<xref ref-type="bibr" rid="B21">
<sup>21</sup>
</xref> The V388M mutation was the most prevalent in our study, similar to results
obtained in the state of Rio de Janeiro,<xref ref-type="bibr" rid="B14">
<sup>14</sup>
</xref> but different from the data found in studies carried out in Ribeirão
Preto/São Paulo<xref ref-type="bibr" rid="B8">
<sup>8</sup>
</xref> and the South of Brazil,<xref ref-type="bibr" rid="B11">
<sup>11</sup>
</xref> where the highest prevalence occurred at exon 7.</p>
<p>The R261Q mutation, located at exon 7, consists of replacing the Arginine (Arg) amino
acid with Glutamine (Glu) at codon 782 (c.782G&gt;A) of the <italic>PAH</italic>
gene, in the catalytic domain. This mutation can be found in several studies
published in Brazil, such as those carried out in Ribeirão Preto/São Paulo in 2001
(12.2%), Rio Grande do Sul and Santa Catarina in 2003 (9.8%), Minas Gerais (16.0%),
the Northeast, where several States participated (8.7%), and Alagoas (35.0%), but
was not identified in the research performed in Campinas/São Paulo in 2008. On the
other hand, R261Q was the second (11,8%) most prevalent mutation in the state of Rio
de Janeiro.<xref ref-type="bibr" rid="B8">
<sup>8</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B9">
<sup>9</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B10">
<sup>10</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B11">
<sup>11</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B12">
<sup>12</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B13">
<sup>13</sup>
</xref>
<sup>,</sup>
<xref ref-type="bibr" rid="B14">
<sup>14</sup>
</xref> In a study conducted in the provinces of Qazvin and Zanjan in Iran in 2015,
V388M was the second most frequent mutation. This mutation is also common in the
Mediterranean and Southern Europe but has a low incidence in Spain.<xref ref-type="bibr" rid="B22">
<sup>22</sup>
</xref>
</p>
<p>Most patients in the research study were males (57.9%), similar to the study
published in Alagoas.<xref ref-type="bibr" rid="B10">
<sup>10</sup>
</xref> The prevalent age range was 3-10 years, which had already been predicted,
since they were SRTN patients. Patients aged &gt;15 had been transferred from other
states. Consanguinity, present in 15.8% of patients, is a deeply rooted social trend
in one-fifth of the world population living in the Middle East, West Asia, and North
Africa, as well as among migrants from these countries residing in North America,
Europe, and Australia.<xref ref-type="bibr" rid="B23">
<sup>23</sup>
</xref> In Brazil, a cross-sectional epidemiological study using the Key Informants
method was conducted in five districts of Rio Grande do Norte, in the Northeast of
Brazil, where frequencies of consanguine marriages ranged between 9 and 32%. On
average, 25% of consanguineous couples and 12% of non-consanguine ones had one or
more children with disabilities. The high prevalence of people with disabilities in
the Brazilian Northeast may be associated with the tradition of consanguine
marriages in these populations, and some of these deficiencies might result from
genetic diseases.<xref ref-type="bibr" rid="B24">
<sup>24</sup>
</xref> Consanguinity can be measured by the inbreeding coefficient (F). Our study
showed marriages between second-degree uncles and nieces and third-degree cousins.
The children’s F was 1/8 and 1/16, respectively.<xref ref-type="bibr" rid="B25">
<sup>25</sup>
</xref>
</p>
<p>In this study, the presence of the most frequent variants was evaluated according to
studies published in Brazil, but only 32% of the mutated alleles were detected.</p>
<p>A study conducted between 2009 and 2014, with families recruited at a genetic
counseling clinic in China, selected 118 fetuses from 112 families. The authors
identified 63 types of mutations, among which R243Q was the most frequent. Out of
the fetuses analyzed, 64 newborns had a normal birth, 31 resulted in abortion, and
23 women were still pregnant at the end of this study. The most prevalent mutation
in the abortion cases was R243Q (16.12%), followed by R413P and EXE-96A&gt;G (9.7%),
and R261Q (8.1%); our study did not analyze the R243Q mutation, though. The
percentage of abortions attributed to the IVS10nt-11G&gt;A mutation was 1.61%.<xref ref-type="bibr" rid="B26">
<sup>26</sup>
</xref> However, the IVS10nt-11G&gt;A mutation is present in our study, proving that
any couple with PKU should have a planned pregnancy with genetic follow-up.</p>
<p>The IVS10nt-11G&gt;A mutation is a type of null mutation located at exon 11 in the
intragenic region at codon 1066 (c.1066-11G&gt;A) in the catalytic domain of the
<italic>PAH</italic> gene. It was present in this work (7.9%), while in Alagoas,
Ribeirão Preto (São Paulo), and the Northeast Region, this mutation was the most
prevalent. In Rio de Janeiro, it was the third most prevalent mutation (10.3%),<xref ref-type="bibr" rid="B14">
<sup>14</sup>
</xref> while being the most frequent one in Portugal and along the Mediterranean
coast, which strongly suggests an East-West migration route, even before
transoceanic traveling.<xref ref-type="bibr" rid="B9">
<sup>9</sup>
</xref> Nonetheless, a study carried out with the Iranian population in 2015 did not
find the same mutation.</p>
<p>According to the PAHdb,<xref ref-type="bibr" rid="B26">
<sup>26</sup>
</xref> missense mutations are the most commonly found (60.1%), with deletion
mutations holding the second place (10.52%). Our study also showed missense
mutations as the most frequent (18.4%), but the second position was held by splice
mutations (13.4%).</p>
<p>The genotype/phenotype correlation followed a model proposed by Guldberg et al. in
1998,<xref ref-type="bibr" rid="B19">
<sup>19</sup>
</xref> which identified two mutations in four patients (21.1%) out of a sample that
included 19 individuals. Four patients presented a classical PKU phenotype, but in
three of them, the actual phenotype did not agree with what had been predicted,
which was moderate/mild or moderate PKU. Thus, agreement between the expected
phenotype and the actual one occurred in 1/19 patients (5.3%).<xref ref-type="bibr" rid="B19">
<sup>19</sup>
</xref>
</p>
<p>In Alagoas, the genotype/phenotype correlation was performed in 14 individuals out of
a sample of 15 patients. Nine patients presented a different genotype from the one
expected - instead of moderate/mild PKU, they had classical PKU, similar to our
study. In the Northeast, 42.7% (38/89) of the individuals showed mild or moderate
PKU, thus establishing a correlation between what was predicted and what was
observed.<xref ref-type="bibr" rid="B9">
<sup>9</sup>
</xref>
<sup>-</sup>
<xref ref-type="bibr" rid="B10">
<sup>10</sup>
</xref>
</p>
<p>A molecular study on tetrahydrobiopterin (BH<sub>4</sub>)-responsive phenylalanine
hydroxylase deficiency verified that BH<sub>4</sub>-responsive <italic>PAH</italic>
had been recently described as a variant of <italic>PAH</italic> deficiency caused
by specific mutations in the <italic>PAH</italic> gene. Studies suggest that the
BH<sub>4</sub> response can be predicted from the corresponding genotypes. Data
from BH<sub>4</sub> loading tests indicated an incidence of BH<sub>4</sub> in
&gt;40% of the general PKU population and &gt;80% of patients with mild PKU. Our
study found R261Q and V388M mutations, which are responsive to BH<sub>4</sub>.
Regarding IVS10nt-11G&gt;A, its use is not yet clear.<xref ref-type="bibr" rid="B27">
<sup>27</sup>
</xref>
</p>
<p> The PKU incidence in this study was 1:33,342. According to the MoH, PNTN coverage in
Brazil was 84% in 2014. The coverage of the screening program in Mato Grosso was
below the national rate from 2003 to 2015, but we underline that the exams performed
in the private health system are not reported to the screening service. The actions
of the ­PNTN/­MT represent a remarkable advance in the secondary prevention of
chronic diseases, even though the state coverage is below national levels. Although
the SRTN has limitations, such as lack of physical space and qualified
professionals, both in the technical and administrative areas, it is considered a
good service for Mato Grosso’s society. A negative point is the lack of governmental
support both at national and state levels. The MoH should organize national
meetings, in which they could discuss the “hits and errors” of each state; there is
also a lack of support from the state government, given that they do not provide
regular training for the accredited health service in Mato Grosso. In addition, the
issues faced by the districts result from a high rate of employee turnover, without
giving new workers information about how the SRTN is organized and its importance.
Hence, there is an increase in inadequate samples and incomplete forms.</p>
<p>Therefore, it is necessary to create strategies to raise awareness among all those
involved, providing continuing education programs, standardizing technical
procedures, and understanding the roles played by each one.</p>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGMENTS</title>
<p>The authors thank the team of the Newborn Screening Reference Service at the Júlio
Müller University Hospital/UFMT for the support in the development of the
research.</p>
</ack>
<fn-group>
<title>Funding</title>
<fn fn-type="supported-by" id="fn1">
<p>This study did not receive funding.</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="B1">
<label>1</label>
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>Online Mendelian Inheritance in Man - OMIM</collab>
</person-group>
<comment>[homepage on the Internet]</comment>
<source/>US: Online Mendelian Inheritance in Man
          <date-in-citation content-type="access-date" iso-8601-date="2016-01-12">2016 Jan
12</date-in-citation>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.omim.org/entry/612349?search=PHENYLKETONURIA&amp;highlight=phenylketonuria">http://www.omim.org/entry/612349?search=
PHENYLKETONURIA&amp;highlight=phenylketonuria</ext-link></comment>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Phenylketonuria: translating research into novel
therapies</article-title>
<source/>Transl Pediatr
          <year>2014</year>
<volume>3</volume>
<fpage>49</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.3978/j.issn.2224-4336.2014.01.01</pub-id>
<pub-id pub-id-type="pmid">26835324</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moghadam</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Shojaei</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Babaei</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Rohani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ghazi</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Mutation analysis of phenylalanine hydroxylase gene in Iranian
patients with phenylketonuria</article-title>
<source/>Med J Islam Repub Iran
          <year>2018</year>
<volume>32</volume>
<fpage>21</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.14196/mjiri.32.21</pub-id>
<pub-id pub-id-type="pmid">30159272</pub-id>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esfahani</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Vallian</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>A comprehensive study of phenylalanine hydroxylase gene mutations
in the Iranian phenylketonuria patients</article-title>
<source/>Eur J Med Genet
          <year>2019</year>
<volume>62</volume>
<fpage>103559</fpage>
<lpage>103559</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2018.10.011</pub-id>
<pub-id pub-id-type="pmid">30389586</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marqui</surname>
<given-names>AB</given-names>
</name>
</person-group>
<article-title>Overview of neonatal screening for phenylketonuria in
Brazil</article-title>
<source/>Medicina (Ribeirao Preto Online)
          <year>2016</year>
<volume>49</volume>
<fpage>517</fpage>
<lpage>525</lpage>
<pub-id pub-id-type="doi">10.11606/issn.2176-7262.v49i6p517-525</pub-id>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Brazil - Ministério da Saúde</collab>
</person-group>
<source/>Fenilcetonúria. Protocolo clínico e diretrizes terapêuticas
          <publisher-loc>Brasília</publisher-loc>
<publisher-name>Ministério da Saúde</publisher-name>
<year>2013</year>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Straneiri</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Takano</surname>
<given-names>OA</given-names>
</name>
</person-group>
<article-title>Evaluation of the Neonatal Screening Program for congenital
hypothyroidism and phenylketonuria in the State of Mato Grosso,
Brazil</article-title>
<source/>Arq Bras Endocrinol Metab
          <year>2009</year>
<volume>53</volume>
<fpage>446</fpage>
<lpage>452</lpage>
<pub-id pub-id-type="doi">10.1590/S0004-27302009000400010</pub-id>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Acosta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>W</given-names>
<suffix>Junior</suffix>
</name>
<name>
<surname>Carvalho</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gomes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zago</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Mutations of the phenylalanine hydroxylase (PAH) gene in
Brazilian patients with phenylketonuria</article-title>
<source/>Hum Mutat
          <year>2001</year>
<volume>17</volume>
<fpage>122</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="doi">10.1002/1098-1004(200102)17:2&lt;122::AID-HUMU4&gt;3.0.CO;2-C</pub-id>
<pub-id pub-id-type="pmid">11180595</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Boa Sorte</surname>
<given-names>TR</given-names>
</name>
</person-group>
<source/>Estudo de bases moleculares de fenilcetonúria no nordeste do
Brasil
          <comment>[PhD thesis]</comment>
<publisher-loc>Salvador (BA)</publisher-loc>
<publisher-name>Fundação Oswaldo Cruz, Centro de Pesquisas Gonçalo
Moniz</publisher-name>
<year>2010</year>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Amorim</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Acosta</surname>
<given-names>AX</given-names>
</name>
</person-group>
<article-title>Genetic and clinical characterization of patients with
phenylketonuria in Alagoas state, Brazil</article-title>
<source/>Sci Med
          <year>2012</year>
<volume>22</volume>
<fpage>64</fpage>
<lpage>70</lpage>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>FB</given-names>
</name>
<name>
<surname>Morari</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fachel</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Pires</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular characterization of phenylketonuria in south
Brazil</article-title>
<source/>Mol Genet Metab
          <year>2003</year>
<volume>79</volume>
<fpage>17</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">12765842</pub-id>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Pollice</surname>
<given-names>EL</given-names>
</name>
</person-group>
<source/>Caracterização molecular da fenilcetonúria em pacientes da região de
Campinas
          <comment>[PhD thesis]</comment>
<publisher-loc>Campinas (SP)</publisher-loc>
<publisher-name>UNICAMP</publisher-name>
<year>2008</year>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Magalhães</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>AO</given-names>
</name>
<name>
<surname>Starling</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Januário</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Fonseca</surname>
<given-names>CG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Frequencies of phenylalanine hydroxylase mutations I65T, R252W,
R261Q, R261X, IVS10nt-11, V388M, R408W, Y414C, and IVS12nt1 in Minas Gerais,
Brazil</article-title>
<source/>Gent Mol Res
          <year>2006</year>
<volume>5</volume>
<fpage>16</fpage>
<lpage>23</lpage>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vieira</surname>
<given-names>E</given-names>
<suffix>Neto</suffix>
</name>
<name>
<surname>Laranjeira</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Quelhas</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Seabra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mineiro</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutation analysis of the PAH gene in phenylketonuria patients
from Rio de Janeiro, Southeast Brazil</article-title>
<source/>Mol Genet Genomic Med
          <year>2018</year>
<volume>6</volume>
<fpage>575</fpage>
<lpage>591</lpage>
<pub-id pub-id-type="doi">10.1002/mgg3.408</pub-id>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blau</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sprosen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>HL</given-names>
</name>
</person-group>
<article-title>Phenylketonuria</article-title>
<source/>Lancet
          <year>2010</year>
<volume>376</volume>
<fpage>1417</fpage>
<lpage>1427</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(10)60961-0</pub-id>
<pub-id pub-id-type="pmid">20971365</pub-id>
</element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marqui</surname>
<given-names>AT</given-names>
</name>
</person-group>
<article-title>Phenylketonuria: genetic aspects, diagnosis and
treatment</article-title>
<source/>Rev Soc Clin Med
          <year>2017</year>
<volume>15</volume>
<fpage>282</fpage>
<lpage>288</lpage>
</element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lahiri</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Nurnberger</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>A rapid non-enzymatic method for the preparation of HMV DNA from
blood ofr RFLP studies</article-title>
<source/>Nucleic Acids Res
          <year>1991</year>
<volume>19</volume>
<fpage>5444</fpage>
<lpage>5444</lpage>
<pub-id pub-id-type="doi">10.1093/nar/19.19.5444</pub-id>
<pub-id pub-id-type="pmid">1681511</pub-id>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saiki</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Gelfand</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Stoffel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Scharf</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Higuchi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Horn</surname>
<given-names>GT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Primer-directed enzymatic amplification of DNA with a
thermostable DNA polymerase</article-title>
<source/>Science
          <year>1988</year>
<volume>239</volume>
<fpage>487</fpage>
<lpage>491</lpage>
<pub-id pub-id-type="doi">10.1126/science.2448875</pub-id>
<pub-id pub-id-type="pmid">2448875</pub-id>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guldberg</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rey</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zschocke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>V</given-names>
</name>
<name>
<surname>François</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Michiels</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A European multicenter study of phenylalanine hydroxylase
deficiency: classification of 105 mutations and a general system for
genotype-based prediction of metabolic phenotype</article-title>
<source/>Am J Hum Genet
          <year>1998</year>
<volume>63</volume>
<fpage>71</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="doi">10.1086/301920</pub-id>
<pub-id pub-id-type="pmid">9634518</pub-id>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desviat</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Pérez</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lucca</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cornejo</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ugarte</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Evidence in Latin America of recurrence of V388M, a
phenylketonuria mutation with Hugh in vitro residual
activity</article-title>
<source/>Am J Hum Genet
          <year>1995</year>
<volume>57</volume>
<fpage>337</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="pmid">7668259</pub-id>
</element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Réblová</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kulhánek</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fajkusová</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Computation study of missense mutations in phenylalanine
hydroxylase</article-title>
<source/>J Mol Model
          <year>2015</year>
<volume>21</volume>
<fpage>70</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1007/s00894-015-2620-6</pub-id>
<pub-id pub-id-type="pmid">25750018</pub-id>
</element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biglari</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Saffari</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rashvand</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Alizadeh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Najafipour</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sahmani</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Mutations of the phenylalanine hydroxylase gene in Iranian
patients with phenylketonuria</article-title>
<source/>Springerplus
          <year>2015</year>
<volume>4</volume>
<fpage>542</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="doi">10.1186/s40064-015-1309-8</pub-id>
<pub-id pub-id-type="pmid">26413448</pub-id>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamamy</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Consanguineous marriages</article-title>
<source/>J Community Genet
          <year>2012</year>
<volume>3</volume>
<fpage>185</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="doi">10.1007/s12687-011-0072-y</pub-id>
<pub-id pub-id-type="pmid">22109912</pub-id>
</element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Melo</surname>
<given-names>US</given-names>
</name>
<name>
<surname>Lopes</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Weller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kok</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>A endogamia explicaria a elevada prevalência de deficiências em
populações do Nordeste brasileiro?</article-title>
<source/>Ciênc Saúde Coletiva
          <year>2013</year>
<volume>18</volume>
<fpage>1141</fpage>
<lpage>1150</lpage>
<pub-id pub-id-type="doi">10.1590/S1413-81232013000400027</pub-id>
</element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Nussbaum</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Mcinnes</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Willard</surname>
<given-names>HF</given-names>
</name>
</person-group>
<source/>Thompson &amp; Thompson: Genética médica
          <edition>7</edition>
<publisher-loc>Rio de Janeiro</publisher-loc>
<publisher-name>Editora Elsevier</publisher-name>
<year>2007</year>
</element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>XD</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>QH</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>XL</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>HF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prenatal diagnosis of Chinese families with
phenylketonuria</article-title>
<source/>Genet Mol Res
          <year>2015</year>
<volume>14</volume>
<fpage>14615</fpage>
<lpage>14628</lpage>
<pub-id pub-id-type="doi">10.4238/2015.November.18.25</pub-id>
<pub-id pub-id-type="pmid">26600521</pub-id>
</element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zurflüh</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Zschocke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lindner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Feillet</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chery</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Burlina</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular genetics of tetrahydrobiopterin-responsive
phenylalanine hydroxilase deficiency</article-title>
<source/>Hum Mutat
          <year>2008</year>
<volume>29</volume>
<fpage>167</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1002/humu.20637</pub-id>
<pub-id pub-id-type="pmid">17935162</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>